Thomas Möller brings over two decades of specialized European life sciences investing experience, serving simultaneously as General Partner at BioMedPartners and Chief Investment Officer at Kickfund where he has helped build a portfolio of 100+ companies. His dual role gives him exposure to both later-stage biotech ventures and ultra-early deep-tech company creation, while his hands-on board experience across clinical-stage European biotech companies like Tricares, Inotrem, and Allecra Therapeutics demonstrates his deep operator-like understanding of therapeutic platforms such as antibody-drug conjugates.